Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

For the past two decades, catheter ablation stole most of the excitement in electrophysiology. Cardiac pacing was seen as necessary but boring. His-bundle pacing earned only modest attention. But at ...

Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today ...

AtaCor, a cardiac rhythm management (CRM) company, develops extravascular defibrillation technologies. Its offerings aim to ...

Background: The purpose of this article is to critically review the data accumulated to date from studies evaluating the hemodynamic and clinical effects of right ventricular apical pacing during ...

Personalized accelerated pacing at 75 bpm showed a reduction in adverse clinical events in HFpEF patients compared to standard 60 bpm pacing. The per-protocol analysis indicated significantly fewer ...

EBR Systems (ASX:EBR) gained FDA approval for WiSE in April 2025 and it is the world’s only wireless endocardial (placed ...

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system has been approved by ...

BARCELONA, SPAIN—Cardiac resynchronization therapy (CRT) using an algorithm designed to minimize unnecessary right ventricular pacing is not superior to conventional CRT in patients with systolic ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...